98%
921
2 minutes
20
Background: The Association of American Medical Colleges instituted a standardized video interview (SVI) for all applicants to emergency medicine (EM). It is unclear how the SVI affects a faculty reviewer's decision on likelihood to invite an applicant (LTI) for an interview.
Objectives: The objective was to determine whether the SVI affects the LTI.
Methods: Nine Accreditation Council of Graduate Medication Education (ACGME)-accredited EM residency programs participated in this prospective, observational study. LTI was defined on a 5-point Likert scale as follows: 1 = definitely not invite, 2 = likely not invite, 3 = might invite, 4 = probably invite, 5 = definitely invite. LTI was recorded at three instances during each review: 1) after typical screening (blinded to the SVI), 2) after unblinding to the SVI score, and 3) after viewing the SVI video.
Results: Seventeen reviewers at nine ACGME-accredited residency programs participated. We reviewed 2,219 applications representing 1,424 unique applicants. After unblinding the SVI score, LTI did not change in 2,065 (93.1%), increased in 85 (3.8%) and decreased in 69 (3.1%; p = 0.22). In subgroup analyses, the effect of the SVI on LTI was unchanged by United States Medical Licensing Examination score. However, when examining subgroups of SVI scores, the percentage of applicants in whom the SVI score changed the LTI was significantly different in those that scored in the lower and upper subgroups (p < 0.0001). The SVI video was viewed in 816 (36.8%) applications. Watching the video did not change the LTI in 631 (77.3%); LTI increased in 106 (13.0%) and decreased in 79 (9.7%) applications (p = 0.04).
Conclusions: The SVI score changed the LTI in 7% of applications. In this group, the score was equally likely to increase or decrease the LTI. Lower SVI scores were more likely to decrease the LTI than higher scores were to increase the LTI. Watching the SVI video was more likely to increase the LTI than to decrease it.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637009 | PMC |
http://dx.doi.org/10.1002/aet2.10331 | DOI Listing |
J Clin Endocrinol Metab
September 2025
University of Rochester, Rochester, NY, USA.
Context: Social determinants of health (SDoH) and race are both well-established factors that influence diabetes outcomes. However, less is understood about how social vulnerability (SV) and race intersect to impact diabetes control.
Objective: To examine the additive impact of SV and race on diabetes control.
J Cyst Fibros
September 2025
Cystic Fibrosis Foundation, Bethesda, MD, USA.
Introduction: Providing care to under-resourced patients places additional burdens on CF care teams, therefore it is important to identify programs that serve disproportionately disadvantaged populations.
Methods: Using the U.S.
Am J Pharm Educ
September 2025
University of Florida College of Pharmacy (Gainesville, Florida. Electronic address:
Objective: To evaluate the geographic distribution of American Society of Health-System Pharmacists (ASHP) Community-Based Pharmacy Residency programs in relation to federally designated areas of healthcare need and social vulnerability across the United States.
Methods: Community-Based Pharmacy Residency Program addresses were collected from September 2023 to September 2024 through a three-phase approach: an initial Qualtrics survey of Residency Program Directors, review of program websites, and telephone call follow-up. The resulting 268 addresses (approximately 80% of U.
Am J Hypertens
August 2025
Department of Internal Medicine and Pediatrics, University of Rochester Medical Center, Rochester, NY.
Background: Hypertension is a leading contributor to morbidity and mortality, disproportionately affecting vulnerable populations. We examined the intersection of social vulnerability and race on blood pressure (BP) control.
Methods: We examined 76,600 patients with hypertension in Western New York State.
J Arthroplasty
August 2025
Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA. Electronic address:
Background: Patients with chronic preoperative opioid use may have worse outcomes after total joint arthroplasty (TJA) than opioid-naïve patients. This study aimed to determine if patients who fill opioid prescriptions before TJA are more likely to have a social determinants of health deficit (SDHD).
Methods: This study included a retrospective, single-institution cohort of patients undergoing TJA for osteoarthritis.